incretin mimetic agents glp 1 receptor agonists GLP-1s & Beyond: Understanding Opportunities Glucagon-like Peptide-1 (GLP-1) AGONIST -
Description
Globally more than 537 million people are having diabetes conditions, and 764 million people are living with obesity
We disclaim all liability for actions you take or fail to take based on any content of this article
Araj-Khodaei M, Ayati MH, Azizi Zeinalhajlou A, et al
We excluded studies on drug-drug interactions between GLP1RAs and anti-hyperglycemic medications
